Clinical trial

A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India

NCT00992654

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Open Label Treatment Access: Maraviroc Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India

Design: EXPANDED_ACCESS · Status: NO LONGER AVAILABLE · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNO_LONGER_AVAILABLE

Study typeEXPANDED_ACCESS

Start dateUnknown

PhaseN/A

Conditions

Human Immunodeficiency Virus (HIV)unresolved

Interventions

Open Label Treatment Access: MaravirocDRUG

Sponsors & collaborators

ViiV Healthcarelead sponsor

Pfizercollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00992654 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.